IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena, Yolanda Brepe, Paola Terranova, Eugenia Silvana Ortega, Guillermo Gabriel Barrenechea, View ORCID ProfileDaniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
doi: https://doi.org/10.1101/2021.03.29.21254554
Rossana Elena Chahla
1Head SI.PRO.SA (Province Health System), Ministry of Health, Tucumán, Argentina
Luis Medina Ruiz
2President of the Medical Executive Secretary, SI.PRO.SA Tucumán, Argentina
Teresa Mena
3Primary Care service network, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Yolanda Brepe
3Primary Care service network, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Paola Terranova
3Primary Care service network, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Eugenia Silvana Ortega
4Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Guillermo Gabriel Barrenechea
4Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Daniel Gustavo Goroso
5Research and Technology Center, Mogi das Cruzes University, Brazil, Human Motor Skill Analysis Laboratory, National University of Tucumán, Tucumán, Argentina
Maria de los Angeles Peral de Bruno
4Health Research Institute, Ministry of Health, SI.PRO.SA, Tucumán, Argentina
Data Availability
Data Sharing Statement Data available:Yes Data types:Participant data with identifiers How to access data:E-mail request for data: mperal{at}fm.unt.edu.ar - Dr. Maria Peral de Bruno Who can access the data:Researchers whose proposed use of the data has been approved Types of analyses:for a specified purpose Mechanisms of data availability:with investigator support
Posted March 30, 2021.
IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena, Yolanda Brepe, Paola Terranova, Eugenia Silvana Ortega, Guillermo Gabriel Barrenechea, Daniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
medRxiv 2021.03.29.21254554; doi: https://doi.org/10.1101/2021.03.29.21254554
IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena, Yolanda Brepe, Paola Terranova, Eugenia Silvana Ortega, Guillermo Gabriel Barrenechea, Daniel Gustavo Goroso, Maria de los Angeles Peral de Bruno
medRxiv 2021.03.29.21254554; doi: https://doi.org/10.1101/2021.03.29.21254554
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)